FASN and bladder transitional cell carcinoma: The results showed that T24-R and UMUC3-R cells were refractory to gemcitabine, and T24-R and UMUC3-R cells with FASN knockdown had restored sensitivity to gemcitabine, indicating that FASN promotes gemcitabine resistance in BLCA (Fig. 7E).